Literature DB >> 10767702

Reactive angioendotheliomatosis in association with the antiphospholipid syndrome.

D Creamer1, M M Black, E Calonje.   

Abstract

A 50-year-old woman with systemic lupus erythematosus developed extensive necrotic skin lesions on her chest and abdomen after the discontinuation of warfarin. The presence of antiphospholipid antibodies suggested a diagnosis of antiphospholipid syndrome. Histopathology from a skin lesion demonstrated marked expansion of the dermal microvasculature by intravascular cellular proliferation and focal thrombosis. The intravascular cells stained positive for the endothelial cell markers CD31 and factor VIII-associated antigen confirming reactive angioendotheliomatosis (RAE). This report is the first to identify RAE occurring in the context of the antiphospholipid syndrome. We suggest that intravascular endothelial proliferation, in concert with thrombosis, contributed to the angio-occlusive pathology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767702     DOI: 10.1016/s0190-9622(00)90269-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

2.  Glomeruloid reactive angioendotheliomatosis in a woman with systemic lupus erythematosus and antiphospholipid syndrome mimicking reticular erythematous mucinosis.

Authors:  Caterina Ferreli; Laura Atzori; Franco Rongioletti
Journal:  JAAD Case Rep       Date:  2020-12-17

3.  Persistent cutaneous abdominal ulcerations secondary to diffuse dermal angiomatosis: an underestimated sign for severe atherosclerosis: A case report.

Authors:  Lidia García-Colmenero; Gemma Martin-Ezquerra; Ignacio Gómez-Martín; Meritxell Mellado Joan; Carlos Barranco; Raquel Albero-González; Judith Villar-García; Ramon M Pujol
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.